New quinoxaline derivatives as potential MT₁ and MT₂ receptor ligands.

New quinoxaline derivatives as potential MT₁ and MT₂ receptor ligands.

Ever since the idea arose that melatonin might promote sleep and resynchronize circadian rhythms, many research groups have centered their efforts on obtaining new melatonin receptor ligands whose pharmacophores include an aliphatic chain of variable length united to an N-alkylamide and a methoxy...

Full description

Bibliographic Details
Main Authors: Ancizu, S. (Saioa), Castrillo, N. (Nerea), Pérez-Silanes, S. (Silvia), Aldana, I. (Ignacio), Monge, A. (Antonio), Delagrange, P. (Philippe), Caignard, D.H. (Daniel-Henry), Galiano, S. (Silvia)
Format: info:eu-repo/semantics/article
Language:eng
Published: MDPI 2012
Subjects:
Sleep disorders
Melatonim
MT1/MT2 receptors
Quinoxalinamide
Quinoxalinurea
Online Access:https://hdl.handle.net/10171/23603

Internet

https://hdl.handle.net/10171/23603

Similar Items